NCT01861522View on ClinicalTrials.gov

The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis

PHASE3CompletedINTERVENTIONAL
Enrollment

473

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Perennial Allergic Rhinitis
Interventions
DRUG

Bepotastine besilate

Two TAU-284 5mg tablets will be taken orally twice a day

DRUG

Placebo

Two Placebo tablets will be taken orally twice a day

Trial Locations (2)

Unknown

Reserch site, Fukuoka

Reserch site, Toyama

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY